Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 10 04:00PM ET
18.70
Dollar change
+0.34
Percentage change
1.85
%
IndexRUT P/E29.10 EPS (ttm)0.64 Insider Own2.92% Shs Outstand24.00M Perf Week-1.01%
Market Cap448.75M Forward P/E22.06 EPS next Y0.85 Insider Trans-0.22% Shs Float23.30M Perf Month24.50%
Income15.45M PEG5.82 EPS next Q0.32 Inst Own98.26% Short Float4.31% Perf Quarter42.21%
Sales285.05M P/S1.57 EPS this Y-51.69% Inst Trans-2.60% Short Ratio4.10 Perf Half Y54.16%
Book/sh8.66 P/B2.16 EPS next Y37.80% ROA5.32% Short Interest1.00M Perf Year40.18%
Cash/sh3.42 P/C5.46 EPS next 5Y5.00% ROE7.91% 52W Range11.12 - 21.10 Perf YTD30.77%
Dividend Est.- P/FCF11.26 EPS past 5Y29.16% ROI6.21% 52W High-11.37% Beta1.20
Dividend TTM- Quick Ratio3.80 Sales past 5Y14.31% Gross Margin72.20% 52W Low68.17% ATR (14)0.90
Dividend Ex-Date- Current Ratio4.37 EPS Y/Y TTM-40.12% Oper. Margin7.53% RSI (14)63.02 Volatility3.67% 5.55%
Employees992 Debt/Eq0.22 Sales Y/Y TTM5.31% Profit Margin5.42% Recom1.80 Target Price24.00
Option/ShortYes / Yes LT Debt/Eq0.20 EPS Q/Q-77.27% Payout0.00% Rel Volume0.73 Prev Close18.36
Sales Surprise-3.84% EPS Surprise14.94% Sales Q/Q5.04% EarningsNov 04 AMC Avg Volume245.14K Price18.70
SMA206.81% SMA5019.34% SMA20032.41% Trades Volume178,909 Change1.85%
Date Action Analyst Rating Change Price Target Change
Nov-05-24Downgrade Oppenheimer Outperform → Perform
Nov-05-24Downgrade BTIG Research Buy → Neutral
Sep-26-24Initiated B. Riley Securities Buy $23
Nov-13-20Upgrade Oppenheimer Perform → Outperform $55
Oct-22-19Initiated Oppenheimer Perform
Aug-07-19Upgrade BTIG Research Neutral → Buy $62
Jun-13-19Initiated Dougherty & Company Buy $80
Jan-02-19Upgrade Northland Capital Under Perform → Market Perform
Jun-04-18Downgrade Northland Capital Market Perform → Under Perform
Feb-27-18Downgrade Northland Capital Outperform → Market Perform
Nov-28-24 09:40AM
Nov-26-24 09:15AM
Nov-19-24 04:05PM
Nov-18-24 07:09AM
Nov-12-24 09:40AM
09:55AM Loading…
Nov-07-24 09:55AM
Nov-04-24 05:30PM
04:30PM
04:05PM
Nov-01-24 09:07AM
Oct-28-24 10:01AM
Oct-21-24 04:05PM
Oct-04-24 06:05AM
Oct-02-24 08:00AM
Sep-25-24 12:02PM
08:00AM Loading…
08:00AM
Sep-20-24 08:38AM
Sep-16-24 08:00AM
Aug-07-24 09:55AM
09:40AM
09:35AM
09:30AM
Aug-06-24 01:59PM
Aug-05-24 06:15PM
05:11PM
04:05PM
Jul-22-24 04:05PM
Jun-27-24 02:03PM
May-21-24 04:05PM
May-08-24 09:40AM
10:48AM Loading…
May-07-24 10:48AM
07:04AM
03:13AM
May-06-24 05:50PM
05:47PM
04:47PM
04:05PM
May-02-24 05:45PM
09:00AM
Apr-26-24 05:45PM
Apr-24-24 07:09AM
Apr-23-24 04:05PM
09:30AM
Apr-18-24 05:45PM
Apr-17-24 09:40AM
09:00AM
Apr-15-24 04:05PM
Apr-12-24 05:45PM
01:53PM
Apr-03-24 12:00PM
Apr-01-24 09:40AM
Mar-14-24 09:40AM
Mar-13-24 09:55AM
Feb-27-24 09:40AM
Feb-26-24 09:55AM
Feb-23-24 09:55AM
Feb-21-24 09:26AM
Feb-20-24 10:39PM
06:34PM
08:40AM
08:11AM
07:38AM
07:30AM
Feb-05-24 04:05PM
Feb-01-24 06:51PM
Jan-29-24 07:30AM
Nov-08-23 07:30AM
Nov-07-23 10:38AM
10:08AM
Nov-06-23 05:44PM
05:03PM
04:05PM
Nov-03-23 08:46AM
Oct-03-23 07:30AM
Oct-02-23 04:05AM
Sep-25-23 08:38AM
Sep-19-23 09:00AM
Sep-07-23 07:30AM
Aug-31-23 04:05PM
Aug-10-23 05:41AM
Aug-07-23 06:05PM
04:58PM
04:05PM
Jul-28-23 09:25PM
Jul-21-23 12:19PM
Jul-18-23 08:00AM
Jul-07-23 12:10PM
Jun-29-23 04:05PM
Jun-09-23 11:48AM
May-26-23 11:18AM
May-23-23 07:30AM
May-10-23 06:10AM
May-09-23 10:52AM
10:42AM
May-08-23 05:55PM
04:53PM
04:05PM
May-03-23 09:57AM
Mar-30-23 04:05PM
Mar-20-23 02:00PM
Tactile Systems Technology, Inc. engages in developing and providing medical devices for the treatment of underserved chronic diseases. It provides lymphedema solutions and offers Flexitouch Plus and Entre Plus systems products. The company was founded on January 30, 1995 and is headquartered in Minneapolis, MN.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Ferstler Sherri LeeSenior VP, SalesAug 12 '24Sale13.071,55020,26338,764Aug 14 04:26 PM
Ferstler Sherri LeeOfficerAug 12 '24Proposed Sale13.071,55020,262Aug 12 05:04 PM
Birkemeyer Elaine M.Chief Financial OfficerMay 16 '24Sale13.683,04141,59061,295May 20 04:36 PM
BURKE WILLIAM WDirectorMay 08 '24Sale14.062,50035,15025,273May 10 04:24 PM
Burns KristieSr. VP Mktg & Clinical AffairsMay 06 '24Sale14.3781511,71362,574May 08 05:23 PM
Burns KristieSr. VP Mktg & Clinical AffairsFeb 27 '24Sale15.581,09117,00163,632Feb 29 08:43 PM
Burns KristieSr. VP Mktg & Clinical AffairsFeb 29 '24Sale15.252433,70663,389Feb 29 08:43 PM
REUVERS DANIEL L.President and CEOFeb 27 '24Sale15.604,68973,148239,423Feb 29 08:42 PM
REUVERS DANIEL L.President and CEOFeb 29 '24Sale15.251,39621,289238,027Feb 29 08:42 PM
REUVERS DANIEL L.President and CEOFeb 26 '24Sale15.816,23998,645244,112Feb 27 09:13 PM
REUVERS DANIEL L.President and CEOFeb 23 '24Sale14.855,37879,853192,321Feb 27 09:13 PM
Burns KristieSr. VP Mktg & Clinical AffairsFeb 23 '24Sale14.802,24933,27853,765Feb 27 09:12 PM
Burns KristieSr. VP Mktg & Clinical AffairsFeb 26 '24Sale15.902,01532,04963,512Feb 27 09:12 PM